PCIBo — PCI Biotech Holding ASA Balance Sheet
0.000.00%
- NOK13.81m
- NOK0.48m
- NOK6.74m
Annual balance sheet for PCI Biotech Holding ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 188 | 116 | 56.6 | 41.2 | 27.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13.2 | 12.2 | 6.16 | 2.57 | 3.84 |
| Total Other Current Assets | |||||
| Total Current Assets | 201 | 128 | 62.8 | 43.8 | 30.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.99 | 7.66 | 0.723 | 0.297 | 0.31 |
| Other Long Term Assets | |||||
| Total Assets | 209 | 136 | 63.5 | 44 | 31.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19.8 | 20.9 | 5.75 | 4.97 | 7.76 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 19.9 | 22.2 | 6.08 | 5.01 | 7.76 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 189 | 114 | 57.4 | 39 | 23.5 |
| Total Liabilities & Shareholders' Equity | 209 | 136 | 63.5 | 44 | 31.2 |
| Total Common Shares Outstanding |